Intravenous thrombolysis in acute ischemic stroke after POLKARD: One center analysis of program impact on clinical practice

Advances in Medical Sciences

Volumn 56, Issue 2, 2011, Pages 231-240

  Arkuszewski, M ^a   Targosz Gajniak, M ^a   Swiat, M ^a   Patalong Ogiewa, M ^a   Pieta, M ^a   Opala, G ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

ischemic stroke; mortality; outcome; proportion; thrombolysis; time delays

Indexed keywords

ALTEPLASE;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN DYSFUNCTION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL PROTOCOL; DISABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; RETROSPECTIVE STUDY; RISK FACTOR; THROMBOSIS;

EID: 84855419015     PISSN: 18961126     EISSN: 18984002     Source Type: Journal    
DOI: 10.2478/v10039-011-0045-8     Document Type: Article

References (59)

1. Czlonkowska A, Ryglewicz D, Weissbein T, Baranska-Gieruszczak M, Hier DB. Prospective Community-Based Study of Stroke in Warsaw Poland.Stroke. 1994. Mar: 25(3) 547-51. (Pubitemid 24067064)
2. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger VL, Rosamond W, Sacco R, Sorlie P, Stafford R, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J, Stroke AHASC. Heart Disease and Stroke Statistics-2010 Update A Report From the American Heart Association. Circulation. 2010 Feb 23;121(7):E46-E215.
3. White H, Albala BB, Wang CL, Elkind MSV, Rundek T, Wright CB, Sacco RL. Ischemic stroke subtype incidence among whites, blacks, and Hispanics-The northern Manhattan study. Circulation. 2005 Mar 15;111(10):1327-1331. (Pubitemid 40389099)
4. Xu J, Kochanek KD, Murphy SL, Tejada-Vera B. Deaths: Final Data for 2007. Natl Vital Stat Rep. 2010 May 20;58(19):1-116.
5. Centers for Disease Control and Prevention (CDC). Prevalence of disabilities and associated health conditions among adults: United States, 1999. MMWR Morb Mortal Wkly Rep. 2001 Feb 23;50(7):120-5
6. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995 Dec 14;333(24):1581-7.
7. Wahlgren N, Ahmed N, Davalos A, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kuelkens S, Larrue V, Lees KR, Roine RO, Soinne L, Toni D, Vanhooren G. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet. 2007 Jan 27;369(9558):275-82. (Pubitemid 46138121)
8. Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008 Sep 25;359(13):1317-29.
9. Topakian R, Brainin M, Eckhardt R, Kiechl S, Ahmed N, Ferrari J, Iglseder B, Wahlgren NG, Lang W, Fazekas F, Willeit J, Aichner FT. Thrombolytic therapy for acute stroke in Austria: data from the Safe Implementation of Thrombolysis in Stroke (SITS) register. Eur J Neurol. 2011 Feb;18(2):306-11.
10. Bambauer KZ, Johnston SC, Bambauer DE, Zivin JA. Reasons why few patients with acute stroke receive tissue plasminogen activator. Arch Neurol. 2006 May;63(5):661-4
11. van den Berg JS and de Jong G. Why ischemic stroke patients do not receive thrombolytic treatment: results from a general hospital. Acta Neurol Scand. 2009 Sep;120(3):157-60.
12. Eriksson M, Jonsson F, Appelros P, Asberg KH, Norrving B, Stegmayr B, Terent A, Asplund K. Dissemination of thrombolysis for acute ischemic stroke across a nation: experiences from the Swedish stroke register, 2003 to 2008. Stroke. 2010 Jun;41(6):1115-22.
13. Fang MC, Cutler DM, Rosen AB. Trends in thrombolytic use for ischemic stroke in the United States. J Hosp Med. 2010 Sep;5(7):406-9.
14. Michel P, Odier C, Rutgers M, Reichhart M, Maeder P, Meuli R, Wintermark M, Maghraoui A, Faouzi M, Croquelois A, Ntaios G. The Acute STroke Registry and Analysis of Lausanne (ASTRAL): design and baseline analysis of an ischemic stroke registry including acute multimodal imaging. Stroke. 2010 Nov;41(11):2491-8.
15. van Wijngaarden JD, Dirks M, Huijsman R, Niessen LW, Fabbricotti IN, Dippel DW. Hospital rates of thrombolysis for acute ischemic stroke: the infuence of organizational culture. Stroke. 2009 Oct;40(10):3390-2.
16. Kobayashi A, Czlonkowska A, Ahmed N, Romanowicz S, Glonek M, Nyka WM, Opala G, Wahlgren N. Intravenous recombinant tissue plasminogen activator for acute stroke in Poland: an analysis based on the Safe Implementation of Thrombolysis in Stroke (SITS) Registry. Acta Neurol Scand. 2010 Oct;122(4):229-36.
17. Wang Y, Liao X, Zhao X, Wang DZ, Wang C, Nguyen-Huynh MN, Zhou Y, Liu L, Wang X, Liu G, Li H. Using recombinant tissue plasminogen activator to treat acute ischemic stroke in China: analysis of the results from the Chinese National Stroke Registry (CNSR). Stroke. 2011 Jun;42(6):1658-64.
18. Huang P, Khor GT, Chen CH, Lin RT, Liu CK. Eligibility and rate of treatment for recombinant tissue plasminogen activator in acute ischemic stroke using different criteria. Acad Emerg Med. 2011 Mar;18(3):273-8.
19. Sung SF, Ong CT, Wu CS, Hsu YC, Su YH. Increased use of thrombolytic therapy and shortening of in-hospital delays following acute ischemic stroke: experience on the establishment of a primary stroke center at a community hospital. Acta Neurol Taiwan. 2010 Dec;19(4):246-52.
20. Dirks M, Niessen LW, van Wijngaarden JD, Koudstaal PJ, Franke CL, van Oostenbrugge RJ, Huijsman R, Lingsma HF, Minkman MM, Dippel DW. Promoting Thrombolysis in Acute Ischemic Stroke. Stroke. 2011 May;42(5):1325-30.
21. Jauss M, Schutz HJ, Tanislav C, Misselwitz B, Rosenow F. Effect of daytime, weekday and year of admission on outcome in acute ischaemic stroke patients treated with thrombolytic therapy. Eur J Neurol. 2010 Apr;17(4):555-61.
22. Sarzynska-Dlugosz I, Skowronska M, Czlonkowska A. Development of the stroke unit network in Poland-current status and future requirements. Neurol Neurochir Pol. 2007 Mar-Apr;41(2):107-12. (Pubitemid 46758815)
23. Safe Implementation of Thrombolysis in Stroke: A Multinational Multicentre Monitoring Study of Safety and Effcacy of Thrombolysis in Stroke protocol. [Internet] Last update: 18 Dec 2002. [cited 2011 Sep 29]; Available from: http://www.acutestroke.org/SM-Protocol/SITS-MOST-fnal- protocol.pdf.
24. Wardlaw JM, Zoppo G, Yamaguchi T, Berge E. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2003;(3):CD000213.
25. Czlonkowska A, Sarzynska-Dlugosz I, Niewada M, Kobayashi A, Ryglewicz D. Evaluation of the accessibility of stroke units in Poland. Neurol Neurochir Pol. 2004 Sep-Oct;38(5):353-60. Polish.
26. Czlonkowska A, Milewska D, Ryglewicz D. The polish experience in early stroke care. Cerebrovasc Dis. 2003;15(Suppl 1):14-5. (Pubitemid 36359452)
27. Kobayashi A, Skowronska M, Litwin T, Czlonkowska A. Lack of experience of intravenous thrombolysis for acute ischaemic stroke does not infuence the proportion of patients treated. Emerg Med J. 2007 Feb;24(2):96-9. (Pubitemid 46210624)
28. Lees KR, Ford GA, Muir KW, Ahmed N, Dyker AG, Atula S, Kalra L, Warburton EA, Baron JC, Jenkinson DF, Wahlgren NG, Walters MR. Thrombolytic therapy for acute stroke in the United Kingdom: experience from the safe implementation of thrombolysis in stroke (SITS) register. QJM. 2008 Nov;101(11):863-9.
29. Evenson KR, Foraker RE, Morris DL, Rosamond WD. A comprehensive review of prehospital and in-hospital delay times in acute stroke care. Int J Stroke. 2009 Jun;4(3):187-99.
30. Adams HP, Jr., del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affrms the value of this guideline as an educational tool for neurologists. Circulation. 2007 May 22;115(20):e478-534.
31. Fonarow GC, Smith EE, Saver JL, Reeves MJ, Bhatt DL, Grau-Sepulveda MV, Olson DM, Hernandez AF, Peterson ED, Schwamm LH. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation. 2011 Feb 22;123(7):750-8.
32. Lindsberg PJ, Happola O, Kallela M, Valanne L, Kuisma M, Kaste M. Door to thrombolysis: ER reorganization and reduced delays to acute stroke treatment. Neurology. 2006 Jul 25;67(2):334-6. (Pubitemid 44305430)
33. Di Legge S, Fang J, Saposnik G, Hachinski V. The impact of lesion side on acute stroke treatment. Neurology. 2005 Jul 12;65(1):81-6. (Pubitemid 40973805)
34. Del Zoppo GJ, Saver JL, Jauch EC, Adams HP, Jr. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke. 2009 Aug;40(8):2945-8.
35. Barrett KM and Meschia JF. Acute ischemic stroke management: medical management. Semin Neurol. 2010 Nov;30(5):461-8.
36. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis. 2008;25(5):457-507.
37. Lansberg MG, Thijs VN, Bammer R, Kemp S, Wijman CA, Marks MP, Albers GW. Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke. Stroke. 2007 Aug;38(8):2275-8. (Pubitemid 47457568)
38. Kazley AS, Hillman DG, Johnston KC, Simpson KN. Hospital care for patients experiencing weekend vs weekday stroke: a comparison of quality and aggressiveness of care. Arch Neurol. 2010 Jan;67(1):39-44.
39. Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology. 2001 Apr 24;56(8):1015-20. (Pubitemid 32336306)
40. Puolakka T, Vayrynen T, Happola O, Soinne L, Kuisma M, Lindsberg PJ. Sequential analysis of pretreatment delays in stroke thrombolysis. Acad Emerg Med. 2010 Sep;17(9):965-9.
41. Wahlgren N, Ahmed N, Eriksson N, Aichner F, Bluhmki E, Davalos A, Erila T, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kohrmann M, Larrue V, Lees KR, Machnig T, Roine RO, Toni D, Vanhooren G. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profle in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST). Stroke. 2008 Dec;39(12):3316-22.
42. Forster A, Gass A, Kern R, Wolf ME, Ottomeyer C, Zohsel K, Hennerici M, Szabo K. Gender differences in acute ischemic stroke: etiology, stroke patterns and response to thrombolysis. Stroke. 2009 Jul;40(7):2428-32.
43. Reeves M, Bhatt A, Jajou P, Brown M, Lisabeth L. Sex differences in the use of intravenous rt-PA thrombolysis treatment for acute ischemic stroke: a meta-analysis. Stroke. 2009 May;40(5):1743-9.
44. Eriksson M, Glader EL, Norrving B, Terent A, Stegmayr B. Sex differences in stroke care and outcome in the Swedish national quality register for stroke care. Stroke. 2009 Mar;40(3):909-14.
45. Shobha N, Sylaja PN, Kapral MK, Fang J, Hill MD. Differences in stroke outcome based on sex. Neurology. 2010 Mar 2;74(9):767-71.
46. De Silva DA, Ebinger M, Davis SM. Gender issues in acute stroke thrombolysis. J Clin Neurosci. 2009 Apr;16(4):501-4.
47. Appelros P, Stegmayr B, Terent A. A review on sex differences in stroke treatment and outcome. Acta Neurol Scand. 2010 Jun;121(6):359-69.
48. Meseguer E, Mazighi M, Labreuche J, Arnaiz C, Cabrejo L, Slaoui T, Guidoux C, Olivot JM, Abboud H, Lapergue B, Raphaeli G, Klein IF, Lavallee PC, Amarenco P. Outcomes of intravenous recombinant tissue plasminogen activator therapy according to gender: a clinical registry study and systematic review. Stroke. 2009 Jun;40(6):2104-10.
49. Kent DM, Selker HP, Ruthazer R, Bluhmki E, Hacke W. The stroke-thrombolytic predictive instrument: a predictive instrument for intravenous thrombolysis in acute ischemic stroke. Stroke. 2006 Dec;37(12):2957-62. (Pubitemid 44900816)
50. Hill MD, Kent DM, Hinchey J, Rowley H, Buchan AM, Wechsler LR, Higashida RT, Fischbein NJ, Dillon WP, Gent M, Firszt CM, Schulz GA, Furlan AJ. Sex-based differences in the effect of intra-arterial treatment of stroke: analysis of the PROACT-2 study. Stroke. 2006 Sep;37(9):2322-5. (Pubitemid 44337177)
51. Mishra NK, Diener HC, Lyden PD, Bluhmki E, Lees KR. Infuence of age on outcome from thrombolysis in acute stroke: a controlled comparison in patients from the Virtual International Stroke Trials Archive (VISTA). Stroke. 2010 Dec;41(12):2840-8.
52. Simpson MA, Dewey HM, Churilov L, Ahmed N, Bladin CF, Schultz D, Markus R, Sturm JW, Levi CR, Blacker DJ, Jannes J, Lindley RI, Parsons MW. Thrombolysis for acute stroke in Australia: outcomes from the Safe Implementation of Thrombolysis in Stroke registry (2002-2008). Med J Aust. 2010 Oct 18;193(8):439-43.
53. Alshekhlee A, Mohammadi A, Mehta S, Edgell RC, Vora N, Feen E, Kale S, Shakir ZA, Cruz-Flores S. Is thrombolysis safe in the elderly?: analysis of a national database. Stroke. 2010 Oct;41(10):2259-64.
54. Strbian D, Sairanen T, Rantanen K, Piironen K, Atula S, Tatlisumak T, Soinne L. Characteristics and outcome of ischemic stroke patients who are free of symptoms at 24 hours following thrombolysis. Cerebrovasc Dis. 2011;31(1):37-42.
55. Blinzler C, Breuer L, Huttner HB, Schellinger PD, Schwab S, Kohrmann M. Characteristics and outcome of patients with early complete neurological recovery after thrombolysis for acute ischemic stroke. Cerebrovasc Dis. 2011;31(2):185-90.
56. Muir KW, Weir CJ, Murray GD, Povey C, Lees KR. Comparison of neurological scales and scoring systems for acute stroke prognosis. Stroke. 1996 Oct;27(10):1817-20. (Pubitemid 26332512)
57. Mishra NK, Lyden P, Grotta JC, Lees KR. Thrombolysis is associated with consistent functional improvement across baseline stroke severity: a comparison of outcomes in patients from the Virtual International Stroke Trials Archive (VISTA). Stroke. 2010 Nov;41(11):2612-7.
58. Boddu DB, Srinivasarao Bandaru VC, Reddy PG, Madhusudan M, Rukmini MK, Suryaprabha T, Jabeen SA, Suvarna A, Jayalakshmi SS, Meena AK, Borgohain R, Kaul S. Predictors of major neurological improvement after intravenous thrombolysis in acute ischemic stroke: a hospital-based study from south India. Neurol India. 2010 May-Jun;58(3):403-6.
59. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC, Jr., Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004 Mar 6;363(9411):768-74.